NO20014372D0 - Isolation and partial characterization of a novel antiprocferative component from human leukocytes - Google Patents

Isolation and partial characterization of a novel antiprocferative component from human leukocytes

Info

Publication number
NO20014372D0
NO20014372D0 NO20014372A NO20014372A NO20014372D0 NO 20014372 D0 NO20014372 D0 NO 20014372D0 NO 20014372 A NO20014372 A NO 20014372A NO 20014372 A NO20014372 A NO 20014372A NO 20014372 D0 NO20014372 D0 NO 20014372D0
Authority
NO
Norway
Prior art keywords
substance
antiprocferative
isolation
novel
component
Prior art date
Application number
NO20014372A
Other languages
Norwegian (no)
Other versions
NO316878B1 (en
NO20014372L (en
Inventor
Carl-Fredrik Naess-Andresen
Original Assignee
Naess Andresen Carl Fredrik
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Naess Andresen Carl Fredrik filed Critical Naess Andresen Carl Fredrik
Priority to NO20014372A priority Critical patent/NO316878B1/en
Publication of NO20014372D0 publication Critical patent/NO20014372D0/en
Priority to PCT/NO2002/000311 priority patent/WO2003022293A1/en
Publication of NO20014372L publication Critical patent/NO20014372L/en
Publication of NO316878B1 publication Critical patent/NO316878B1/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07G—COMPOUNDS OF UNKNOWN CONSTITUTION
    • C07G11/00—Antibiotics

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)

Abstract

The present invention relates to a purified leukocyte substance isolated from animals or humans, as well as fragments and/or derivatives/analogues thereof, and a method to isolate and purify this substance. Furthermore, the present invention relates to a pharmaceutical preparation comprising the substance/fragments/derivatives, as well as methods for isolating and purifying said substance, the use of said substance and a method for treating, preventing, inhibiting or ameliorating infections or conditions in a human or an animal caused by microorganisms.
NO20014372A 2001-09-07 2001-09-07 Isolated and substantially purified compound, method, pharmaceutical composition and use NO316878B1 (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
NO20014372A NO316878B1 (en) 2001-09-07 2001-09-07 Isolated and substantially purified compound, method, pharmaceutical composition and use
PCT/NO2002/000311 WO2003022293A1 (en) 2001-09-07 2002-09-05 Novel antimicrobial substance from human leukocytes

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
NO20014372A NO316878B1 (en) 2001-09-07 2001-09-07 Isolated and substantially purified compound, method, pharmaceutical composition and use

Publications (3)

Publication Number Publication Date
NO20014372D0 true NO20014372D0 (en) 2001-09-07
NO20014372L NO20014372L (en) 2003-03-10
NO316878B1 NO316878B1 (en) 2004-06-07

Family

ID=19912811

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20014372A NO316878B1 (en) 2001-09-07 2001-09-07 Isolated and substantially purified compound, method, pharmaceutical composition and use

Country Status (2)

Country Link
NO (1) NO316878B1 (en)
WO (1) WO2003022293A1 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN104622777A (en) * 2015-02-15 2015-05-20 广州赛莱拉干细胞科技股份有限公司 Leukocyte extract and preparation method and application thereof

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2482099A (en) * 1998-01-29 1999-08-16 Yash Sharma Blood cell composition as a vaccine for hiv and other pathogenic organisms

Also Published As

Publication number Publication date
NO316878B1 (en) 2004-06-07
NO20014372L (en) 2003-03-10
WO2003022293A1 (en) 2003-03-20

Similar Documents

Publication Publication Date Title
MXPA05004247A (en) Chromones and chromone derivatives and uses thereof.
WO2004005264A3 (en) Imidazole compounds for the treatment of hepatitis c virus infections
WO2005013892A3 (en) Hydrolytically-resistant boron-containing therapeutics and methods of use
NO20045521L (en) Diarylurea derivatives useful for the treatment of protein kinase-dependent diseases
MXPA05012061A (en) Preparation and use of aryl alkyl acid derivatives for the treatment of obesity.
EA200300944A1 (en) ACYLATED PIPERIDINE DERIVATIVES AS AN AGONISTS OF MELANOCORTIN RECEPTOR-4
NO20052928L (en) New chemical compounds
ATE522528T1 (en) VIRAL INHIBITORS
ATE411280T1 (en) PHENOXYACETIC ACID DERIVATIVES FOR THE TREATMENT OF RESPIRATORY DISORDERS
TNSN04203A1 (en) Benzoxazinone-derived compounds, their preparation and use as medicaments
EP1854886A3 (en) Cold-adapted equine influenza viruses
EA200601212A1 (en) PHOSPHODESTERASE INHIBITORS, OBTAINING AND THEIR THERAPEUTIC APPLICATION
ATE432278T1 (en) COMPOUNDS FOR TREATING DISEASES
CY1108808T1 (en) MOTORCYCLE UNITS
ATE412646T1 (en) THERAPEUTIC AGENTS SUITABLE FOR THE TREATMENT OF PAIN
MXPA05010440A (en) Isoquinoline-5-sulfonic acid amides as inhibitors of akt (protein kinase b).
BRPI0415179A (en) amide derivatives such as ion channel ligands and pharmaceutical compositions and methods of employing them
WO2001060849A3 (en) Cold-adapted equine influenza viruses
ATE338036T1 (en) BENZOFURAN AND BENZOTHIOPHENE DERIVATIVES SUITABLE FOR THE TREATMENT OF HYPERPROLIFERATIVE DISEASES
ATE367380T1 (en) PIPERAZINYLQUINOLINE DERIVATIVES SUITABLE FOR THE TREATMENT OF CNS DISEASES
ATE368110T1 (en) COMPOSITION AND METHOD FOR TREATING IMMUNE-RELATED DISEASES
HK1121670A1 (en) Preparation and composition of inter-alpha inhibitor proteins from human plasma for therapeutic use
DE602004028574D1 (en) COMPOSITIONS AND METHODS FOR TREATING IRRITATION SYNDROME AND NONULCEREOUS DYSPEPSY
ATE290857T1 (en) BRETYLIUM-CONTAINING COMPOSITIONS AND KITS AND THE USE THEREOF FOR PREVENTING AND TREATING CARDIOVASCULAR DISEASES
HK1041884A1 (en) Tan-1057 derivatives

Legal Events

Date Code Title Description
MM1K Lapsed by not paying the annual fees